ArticlePloS one2016
Nivolumab versus Cabozantinib: Comparing Overall Survival in Metastatic Renal Cell Carcinoma.
Witold Wiecek et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this paperpooled itcites it
ArticlePloS one2016
Witold Wiecek et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.